Levomedical
  • Home
  • Therapy
    • How it works
    • How to get started
    • Levo Gen 2
    • FAQ
  • For Professionals
    • Why Levo Gen 2
    • Platform features
    • Care models
  • Resources
  • Start Evaluation
Select Page
U.S. Patent 9,301,714 B2: systems and methods for tracking and presenting tinnitus therapy data

U.S. Patent 9,301,714 B2: systems and methods for tracking and presenting tinnitus therapy data

by Jose Ignacio Duro | Apr 5, 2016 | FDA & patents

  • Follow
  • Follow
  • Follow
  • Follow


+1 (866) 306-1387



info@levomedical.com

Regulatory Info

Privacy Policy

© 2026 Levo Medical Corporation

Levomedical updates

Research, resources and clinical advances on tinnitus, straight to your inbox.

No spam. Unsubscribe anytime. Privacy Policy

Almost there! We have sent you an email to confirm your subscription. Check your inbox (or spam folder) and click the confirmation button.

Request to join the Levo Clinical Network

Tell us about your practice to request an informational meeting.


0 / 180